
The recommendation from the American Academy of Pediatrics (AAP) follows the unanimous recommendation by the CDC advisory group for routine use of nirsevimab in newborns and infants younger than 8 months born into or entering their first RSV season.

The recommendation from the American Academy of Pediatrics (AAP) follows the unanimous recommendation by the CDC advisory group for routine use of nirsevimab in newborns and infants younger than 8 months born into or entering their first RSV season.

Share this link with your patients' parents so they can review the latest back-to-school tips for them and their child as the fall approaches.

Basis for a Biologics License Application submission to the FDA is being built for PXVX0317, following topline results demonstrated in a pair of phase 3 trials, including 1 trial featuring adolescents and adults aged 12 to 64 years.

Study authors stated that several past studies have put focus on training an independent model separately for lung or heart sound diagnosis but note that having a model that can “simultaneously detect abnormal lung and heart sounds,” is essential.

Results of the randomized, multi-site study demonstrated the importance of early diabetes detection, as a single episode of diabetic ketoacidosis (DKA) in young children with type 1 diabetes was associated with lower IQ scores soon after exposure.

Industry analyst reviews cybersecurity for first half of the year, and the results aren’t good.

Tretinoin and benzoyl peroxide Cream, 0.1%/3% (Twyneo; Galderma) , is a breakthrough prescription topical acne treatment that combines the 2 key ingredients tretinoin and benzoyl peroxide.

The resubmission, which included new long-term follow-up data and a post-hoc propensity match study, was issued a complete response letter by the federal agency, which requires “more data to support marketing approval,” according to a press release from Mesoblast Limited.

Jeanne Franzone, MD, orthopedic surgeon, surgical director, Osteogenesis Imperfecta Clinic, co-director, Prosthesis Clinic, Nemours Children’s Health, Delaware Valley, discusses recent technology, recommendations, and interactions with general health care providers in this Contemporary Pediatrics® interview.

After this summer’s Canadian wildfires, should we be concerned about future air quality emergencies? This article was originally published on our sister publication’s website, Drug Topics®.

As children get ready to return to school, pediatric health care providers may start seeing more of this condition in their offices. Here is what you should know.

The authors noted that right-sided EA is often misdiagnosed as acute appendicitis, and that steady but sharp and nonmigratory pain in either of the lower abdominal quadrants should raise suspicion of EA.

To combat this association, study investigators concluded a reduction in daily soft drink consumption should be a priority among school-going adolescents.

84% of health care providers report they have seen an increase in patient stress levels and mental health issues in the past three years.

In this Contemporary Pediatrics® interview, Samir Gautam, MD, (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, senior author of a recently published study in the Journal of Allergy and Clinical Immunology: In Practice, reviews key findings of the study and explains how they relate to the pediatric population. Watch the full interview below.

In a recent study, improved knowledge on preterm birth risks were seen in patients receiving a smartphone-based preterm birth education program.

This expanded upon the limited data available on risks of precautionary allergen label food introduction for those with allergies, the results of which suggest new possibilities for future allergy management.

The authors noted that there is evidence that recommending early introduction of peanut without prior testing is safe and effective in increasing early peanut introduction to infants, even those at high risk.

The prospective cohort study evaluates the role of both subjective and objective experiences.

Early intervention for vision screenings is integral for promoting and maintaining eye health in young children. Pediatricians should watch for and educate parents on signs and symptoms of possible vision problems.

The ACIP voted in unanimous fashion, 10 to 0, to recommend routine use of nirsevimab-alip for newborns and infants younger than 8 months, born during or entering the first RSV season according to a press release from Sanofi.

This recent research indicates the necessity for clinicians to be aware of the higher autoimmune disease susceptibility of those with previous rotavirus-associated hospitalization.

In the 18 studies that assessed the efficacy of closing a patent ductus arteriosus after 1 course of acetaminophen treatments, the results demonstrated that both oral and IV preparations were more effective than placebo.

In a recent study, no significant differences in math and reading test scores were found among children born at term with different gestational ages.

In a letter addressed to the public, the FDA and Drug Enforcement Agency stated that prescription stimulant drug shortages are impacting patients and their families The agencies are taking a multifaceted approach to mitigate these shortages and find potential solutions.

Updated guidance for pediatricians that interact with children and their families, who need a potentially life-saving organ donation or transplantation, has been released by the American Academy of Pediatrics (AAP).

In this review article, take a look back at the top-performing stories from Contemporary Pediatrics from April to August 2023. With each article highlighted below, you’ll find updated news and notes along with a quick recap and direct link to our most-viewed articles.

Better technology is good for patient health and the financial health of physicians’ practices.

In a recent study, the prevalence of autism spectrum disorder was greater in children exposed to maternal labor epidural analgesia and oxytocin use during delivery.

Ervebo has been approved by the FDA to prevent the Ebola virus for individuals aged 12 months and older, after being initially approved for those 18 years and older in 2019.